Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

One Reason I Will Hold Onto My AbbVie Shares Forever - The Globe and Mail

12 Feb, 2026

AbbVie Files Lawsuit Against HHS and CMS Over Botox's Inclusion in Drug Price Negotiation Initiative - BioSpace

12 Feb, 2026

Factors Expected to Propel AbbVie's Revenue Growth in 2026 - The Globe and Mail

10 Feb, 2026

(02/06/26) Best Selections for 2026: AbbVie Inc. (ABBV) - MoneyShow

06 Feb, 2026

See More